Does UPADACITINIB Cause Upper respiratory tract infection? 356 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 356 reports of Upper respiratory tract infection have been filed in association with UPADACITINIB (Rinvoq). This represents 0.5% of all adverse event reports for UPADACITINIB.
356
Reports of Upper respiratory tract infection with UPADACITINIB
0.5%
of all UPADACITINIB reports
14
Deaths
77
Hospitalizations
How Dangerous Is Upper respiratory tract infection From UPADACITINIB?
Of the 356 reports, 14 (3.9%) resulted in death, 77 (21.6%) required hospitalization, and 13 (3.7%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which UPADACITINIB Alternatives Have Lower Upper respiratory tract infection Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL